Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19
Public ClinicalTrials.gov record NCT04389450. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Phase II Study to Evaluate the Efficacy and Safety of Intramuscular Injections of PLX PAD for the Treatment of Severe COVID-19
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This clinical trial will examine if a new treatment of Mesenchymal-like Adherent stromal Cells (called PLX-PAD) can help patients intubated and mechanically ventilated due to COVID-19 to recover more quickly with less complications.
Study identification
- NCT ID
- NCT04389450
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 66 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 40 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 1, 2020 (Actual)
- Primary completion
- May 17, 2021 (Actual)
- Completion
- Jun 7, 2023 (Actual)
- Last update posted
- Aug 30, 2024
2020 – 2023
United States locations
- U.S. sites
- 13
- U.S. states
- 7
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California Irvine | Irvine | California | 92868 | — |
| University of Southern California (USC) - Keck School of Medicine (KSOM) | Los Angeles | California | 90033 | — |
| University Of California Davis,4860 Y Street | Sacramento | California | 95817 | — |
| Baptist Health Medical Center | Jacksonville | Florida | 32207 | — |
| Medical College of Georgia at Augusta University | Augusta | Georgia | 30907 | — |
| Sarah Cannon Research Institute, LLC (Mercer University School of Medicine) | Macon | Georgia | 31217 | — |
| University of Mississippi Medical Center | Jackson | Mississippi | 39216 | — |
| Cooper Research Institute | Camden | New Jersey | 08103 | — |
| Holy Medical Center | Teaneck | New Jersey | 07666 | — |
| Montefiore Medical Center | New York | New York | 10467 | — |
| Maimonides Medical Center | New York | New York | 11219 | — |
| Mercy Medical Center | New York | New York | 11570 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04389450, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 30, 2024 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04389450 live on ClinicalTrials.gov.